Irritable Bowel Syndrome Risk in Acne Patients: Implications for Dermatologic Care

Authors

Alex Y. Liu, Macon & Joan Brock Virginia Health Sciences at Old Dominion UniversityFollow
Ana Ormaza Vera, Macon & Joan Brock Virginia Health Sciences at Old Dominion UniversityFollow
Clinton W. Enos, Macon & Joan Brock Virginia Health Sciences at Old Dominion UniversityFollow

ORCID

0009-0004-4995-841X (Ormaza Vera), 0000-0002-6783-1904 (Enos)

Document Type

Article

Publication Date

2025

DOI

10.12788/cutis.1238

Publication Title

Cutis

Volume

116

Issue

1

Pages

32-35

Abstract

[Practice points]

• Clinicians should consider monitoring for early signs of irritable bowel syndrome (IBS) in adult patients with acne to facilitate prompt diagnosis and intervention.
• Clinicians should remain judicious when prescribing antibiotics for acne management to minimize potential disruptions to the gut microbiota and the risk for IBS.
• Isotretinoin may serve as a safer alternative to antibiotics in patients with acne, particularly those with gastrointestinal concerns.

Rights

© 2025 Frontline Medical Communications Inc. All rights reserved.

Included with the kind written permission of the copyright holder.

Original Publication Citation

Liu, A. Y., Ormaza Vera, A., & Enos, C. W. (2025). Irritable bowel syndrome risk in acne patients: Implications for dermatologic care. Cutis, 116(1), 32-35. https://doi.org/10.12788/cutis.1238

Repository Citation

Liu, A. Y., Ormaza Vera, A., & Enos, C. W. (2025). Irritable bowel syndrome risk in acne patients: Implications for dermatologic care. Cutis, 116(1), 32-35. https://doi.org/10.12788/cutis.1238